Why CNMD lags the market
Down 66% over five years while the S&P 500 rose 58%; up 15% in the past year.
- Its Oct 28 results cut the net sales outlook to $1.36B to $1.37B,
Down 66% over five years while the S&P 500 rose 58%; up 15% in the past year.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| Since its 2022 high | Down 70% |
| Latest filing | 8-K, Oct 28 |
After its last 4 reports it closed +1.8% on average, higher 2 of 4 times.
Below Averagefor quality, not price, 0 of 14 chart checks firingWhat the Quality Score means
CNMD is #45 of 86 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 45 |
Expected to report Wed Jan 27, after the close (in 67 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
A profit of $0.66 a share, from $0.09.
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| General Surgery | $187M | $191M | $200M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Oct 28)
No outlook figures read from this release.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Oct 28, 2026 | -4.7% | -0.1% | +17.3% |
| Jul 29, 2026 | +9.9% | +8.7% | +14.1% |
| Apr 29, 2026 | +3.0% | +1.9% | +3.8% |
Sales grew in six of the last seven years, to $1.4B in 2025. It made a profit in seven of the eight years.
RSI 42.8, MACD below signal, below its 50-day, above its 200-day. Not scored.
No insider bought or sold CNMD in the last six months.
3 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: CNMD is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
“We compete in orthopedic and general surgery medical device markets across the world.”
CNMD scores 3 today, which Breakaway calls Below Average. It is #45 of 86 in Medical Devices by Quality Score, with 0 of 14 chart checks firing. Down 66% over five years while the S&P 500 rose 58%; up 15% in the past year. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
CNMD scores 3 today, which Breakaway calls Below Average (0 to 5). That is #45 of 86 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind CNMD's 3.
Expected to report Wed Jan 27, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. CNMD closed higher after 2 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.